Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A report on ocusert (author's transl)].

K Heilmann

    Klinische Monatsblatter Fur Augenheilkunde
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    The Ocular Therapeutic System Ocusert, using pilocarpine, showed no negative effects after 24 months. Intraocular pressure reduction was found to be reversible with this ocular drug delivery system.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis.

    Mucosal immunology·2017
    Same author

    Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.

    Oncogene·2017
    Same author

    The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis.

    European journal of microbiology & immunology·2014
    Same author

    IgA antibody production by intrarectal immunization of mice using recombinant major capsid protein of hamster polyomavirus.

    European journal of microbiology & immunology·2014
    Same author

    CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria.

    Cell death and differentiation·2007
    Same author

    The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.

    Journal of biotechnology·2005
    Same journal

    Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    [Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

    Klinische Monatsblatter fur Augenheilkunde·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Pharmacology
    • Biomedical Engineering

    Context:

    • The Ocular Therapeutic System Ocusert is a sustained-release drug delivery system for ocular conditions.
    • This study evaluates the long-term safety and efficacy of the Ocusert system with pilocarpine over 24 months.

    Purpose:

    • To assess the clinical outcomes of continuous pilocarpine administration via the Ocusert system.
    • To evaluate potential morphological changes and drug sensitivity over a 24-month period.
    • To determine the reversibility of intraocular pressure reduction using placebo inserts.

    Summary:

    • A 24-month follow-up study of the Ocular Therapeutic System Ocusert demonstrated no clinically significant morphological changes or decreased sensitivity to pilocarpine.
    • Diurnal and regression curve analyses confirmed the sustained efficacy and safety profile.

    Related Experiment Videos

  • An omission test using placebo units indicated that the intraocular pressure-lowering effect of pilocarpine is reversible.

    • Impact:

    • Provides evidence for the long-term safety and tolerability of the Ocusert pilocarpine system.
    • Supports the use of sustained-release drug delivery for chronic ocular conditions like glaucoma.
    • Highlights the reversible nature of pilocarpine's therapeutic effect, crucial for treatment management.